ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,113.74
      1.29%
      US Tech 100
      17,284.80
      1.81%
      Dow Jones
      38,331.45
      0.64%
      Brent Oil
      88.275
      0.14%
      Bitcoin
      63,915.43
      -0.88%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Italy
      5. BIT
      6. Sanofi (SANF)

      7. Sanofi (SANF) News

      SANF Sanofi

      0.00
      0.00 (0.00%)
      - - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Sanofi SANF Italy Ordinary Share
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% -
      Open Price Low Price High Price Close Price Prev Close
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/202401:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
      4/23/202401:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
      4/17/202401:00GLOBEPress Release: New 48-week frexalimab phase 2 data support..
      4/12/202414:05GLOBESanofi: Information concerning the total number of voting..
      4/08/202412:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
      3/22/202402:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
      3/15/202415:04GLOBESanofi: Informations relatives au nombre de droits de vote..
      3/11/202402:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
      2/24/202409:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
      2/23/202412:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
      2/23/202401:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
      2/22/202413:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
      2/20/202417:40GLOBESanofi: Informations relatives au nombre de droits de vote..
      2/16/202401:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
      2/15/202408:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
      2/05/202402:00GLOBEPress Release: Peer support, flexible work arrangements,..
      2/01/202401:30GLOBEPress Release: Sanofi Delivers Solid Sales and Business EPS..
      1/25/202414:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
      1/23/202401:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
      1/17/202416:57GLOBESanofi: Information concerning the total number of voting..
      1/09/202401:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
      12/21/202301:30GLOBEPress Release: Sanofi announces end of program evaluating..
      12/18/202315:59GLOBESanofi: Information concerning the total number of voting..
      12/15/202301:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
      12/15/202301:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
      12/11/202316:08GLOBECommuniqué de presse : Déclaration au sujet de la..
      12/10/202319:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
      12/07/202301:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
      12/06/202321:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
      11/27/202301:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
      11/23/202312:00GLOBESanofi: Information concerning the total number of voting..
      10/27/202301:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
      10/27/202301:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
      10/22/202315:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
      10/19/202306:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
      10/18/202304:45GLOBECommuniqué de presse : Des données de ph III présentées au..
      10/17/202314:18GLOBESanofi: Informations relatives au nombre de droits de vote..
      10/13/202310:00GLOBECommuniqué de presse : Des données de phase IIb de dernière..
      10/04/202301:00GLOBECommuniqué de presse : Sanofi et Teva annoncent une..
      10/03/202301:30GLOBECommuniqué de presse : Sanofi annonce un accord sur un..
      9/26/202301:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
      9/25/202303:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
      9/22/202301:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
      9/19/202302:30GLOBECommuniqué de presse : Sanofi soutient les communautés..
      9/11/202314:02GLOBESanofi: Information concerning the total number of voting..
      8/31/202301:30GLOBEPress Release: Sanofi announces changes to its Executive..
      8/15/202315:24GLOBESanofi: Information concerning the total number of voting..
      8/03/202315:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..
      7/28/202307:22GLOBEPress release: Online availability of Sanofi’s half-year..
      7/28/202301:32GLOBEPress Release: Sanofi to acquire Qunol®, a fast-growing U.S...

      Your Recent History

      BIT
      SANF
      Sanofi
      Delayed Upgrade Clock